SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jonathan Skupsky, Ke-Qin Hu, Current hepatitis B treatment guidelines and future research directions, Frontiers of Medicine, 2014, 8, 2, 145

    CrossRef

  2. 2
    Jia-Feng Wu, Wen-Yu Tsai, Yi-Ching Tung, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu, Mei-Hwei Chang, Effect of Menarche Onset on the Clinical Course in Females with Chronic Hepatitis B Virus Infection, The Journal of Pediatrics, 2014,

    CrossRef

  3. 3
    Christian Trépo, Henry L Y Chan, Anna Lok, Hepatitis B virus infection, The Lancet, 2014,

    CrossRef

  4. 4
    Donna D. Yu, Wenwei Lin, Barry M. Forman, Taosheng Chen, Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor, Bioorganic & Medicinal Chemistry, 2014, 22, 11, 2919

    CrossRef

  5. 5
    Yi-Cheng Chen, Yun-Fan Liaw, Immunotolerant HBeAg Positive Patients: To Treat or Not to Treat, Current Hepatology Reports, 2014, 13, 3, 245

    CrossRef

  6. 6
    Senem C. Karataylı, Mithat Bozdayı, Ersin Karataylı, Tuğba Öztürk, Abbas A. Husseini, Rabia Albayrak, Muhip Özkan, Zeynep Kalaylıoğlu, Kendal Yalçın, Kubilay Çınar, Ramazan İdilman, Cihan Yurdaydın, Interleukin-28 gene polymorphisms may contribute to HBsAg persistence and the development of HBeAg-negative chronic hepatitis B, Liver International, 2014, 34, 8
  7. 7
    C Hu, D Liu, Y Zhang, G Lou, G Huang, B Chen, X Shen, M Gao, W Gong, P Zhou, S Dai, Y Zeng, F He, LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells, Oncogene, 2014, 33, 22, 2888

    CrossRef

  8. You have free access to this content8
    J. C. Hsiang, G. L.-H. Wong, H. L.-Y. Chan, A. W.-H. Chan, A. M.-L. Chim, V. W.-S. Wong, Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B, Alimentary Pharmacology & Therapeutics, 2014, 40, 6
  9. 9
    D Xiang, C-C Liu, M-J Wang, J-X Li, F Chen, H Yao, B Yu, L Lu, U Borjigin, Y-X Chen, L Zhong, K J Wangensteen, Z-Y He, X Wang, Y-P Hu, Non-viral FoxM1 gene delivery to hepatocytes enhances liver repopulation, Cell Death and Disease, 2014, 5, 5, e1252

    CrossRef

  10. 10
    Mehlika Toy, Joshua A. Salomon, Hao Jiang, Honglian Gui, Hui Wang, Jiangshe Wang, Jan Hendrik Richardus, Qing Xie, Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China, Hepatology, 2014, 60, 1
  11. 11
    Maria Nordin, Mikael Ingman, Beata Lindqvist, Karin Kidd-Ljunggren, Variability in the precore and core promoter region of the hepatitis B virus genome, Journal of Medical Virology, 2014, 86, 3
  12. 12
    C-H Chiang, H-I Yang, C-L Jen, S-N Lu, L-Y Wang, S-L You, J Su, U H Iloeje, C-J Chen, Association between obesity, hypertriglyceridemia and low hepatitis B viral load, International Journal of Obesity, 2013, 37, 3, 410

    CrossRef

  13. 13
    Frank G. Schaap, Michael Trauner, Peter L. M. Jansen, Bile acid receptors as targets for drug development, Nature Reviews Gastroenterology & Hepatology, 2013, 11, 1, 55

    CrossRef

  14. 14
    Tai-Chung Tseng, Jia-Horng Kao, Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog, Journal of Gastroenterology, 2013, 48, 1, 13

    CrossRef

  15. 15
    Chien-Hung Chen, Chuan-Mo Lee, Jing-Houng Wang, Tsung-Hui Hu, Chao-Hung Hung, Chi-Sin Changchien, Sheng-Nan Lu, Combination and evolution of HBV mutant strains in the HBeAg-positive status predict clinical outcomes after HBeAg seroconversion, Hepatology International, 2013, 7, 2, 477

    CrossRef

  16. 16
    Shih-Cheng Yang, Sheng-Nan Lu, Chuan-Mo Lee, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Chi-Sin Changchien, Chien-Hung Chen, Combining the HBsAg decline and HBV DNA levels predicts clinical outcomes in patients with spontaneous HBeAg seroconversion, Hepatology International, 2013, 7, 2, 489

    CrossRef

  17. 17
    Donna D. Yu, Wenwei Lin, Taosheng Chen, Barry M. Forman, Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery, Bioorganic & Medicinal Chemistry, 2013, 21, 14, 4266

    CrossRef

  18. 18
    Tai-Chung Tseng, Jia-Horng Kao, Evolution of viral biomarkers in predicting outcomes of chronic hepatitis B patients: From DNA to surface antigen, Tzu Chi Medical Journal, 2013, 25, 2, 75

    CrossRef

  19. 19
    Yuan Yang, Li Jin, Ying-Li He, Ke Wang, Xiao-Hua Ma, Jing Wang, Zhi Yan, Yu-Ling Feng, Yong-Qin Li, Tian-Yan Chen, Hong-Li Liu, Ying-Ren Zhao, Hepatitis B virus infection in clustering of infection in families with unfavorable prognoses in northwest China, Journal of Medical Virology, 2013, 85, 11
  20. You have free access to this content20
    George V. Papatheodoridis, Hepatitis B virus treatment: Which patients can have treatment deferred?, Clinical Liver Disease, 2013, 2, 1
  21. 21
    Yan J. Pang, Xiao J. Tan, Dong M. Li, Zi H. Zheng, Rui X. Lei, Xiao M. Peng, Therapeutic potential of furin inhibitors for the chronic infection of hepatitis B virus, Liver International, 2013, 33, 8
  22. 22
    Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, Henry Lik Yuen Chan, Rong-Nan Chien, Chun-Jen Liu, Ed Gane, Stephen Locarnini, Seng-Gee Lim, Kwang-Hyub Han, Deepak Amarapurkar, Graham Cooksley, Wasim Jafri, Rosmawati Mohamed, Jin-Lin Hou, Wan-Long Chuang, Laurentius A. Lesmana, Jose D. Sollano, Dong-Jin Suh, Masao Omata, Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update, Hepatology International, 2012, 6, 3, 531

    CrossRef

  23. 23
    Yi–Cheng Chen, Wen–Juei Jeng, Chia–Ming Chu, Yun–Fan Liaw, Decreasing Levels of HBsAg Predict HBsAg Seroclearance in Patients With Inactive Chronic Hepatitis B Virus Infection, Clinical Gastroenterology and Hepatology, 2012, 10, 3, 297

    CrossRef

  24. 24
    G. K. K. Lau, F.-S. Wang, Management of Chronic Hepatitis B e Antigen-Negative Disease: Another Step Forward, Journal of Infectious Diseases, 2012, 205, 1, 7

    CrossRef

  25. 25
    Y.-C. Chen, S.-F. Huang, C.-M. Chu, Y.-F. Liaw, Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion, Journal of Viral Hepatitis, 2012, 19, 2
  26. 26
    T.-C. Tseng, C.-J. Liu, C.-L. Chen, C.-C. Wang, T.-H. Su, S. F.-T. Kuo, P.-J. Chen, D.-S. Chen, J.-H. Kao, Serum Hepatitis B Virus-DNA Levels Correlate With Long-term Adverse Outcomes in Spontaneous Hepatitis B e Antigen Seroconverters, Journal of Infectious Diseases, 2012, 205, 1, 54

    CrossRef

  27. 27
    J.-F. Wu, C.-H. Chen, Y.-H. Ni, Y.-T. Lin, H.-L. Chen, H.-Y. Hsu, M.-H. Chang, Toll-like Receptor and Hepatitis B Virus Clearance in Chronic Infected Patients: A Long-Term Prospective Cohort Study in Taiwan, Journal of Infectious Diseases, 2012, 206, 5, 662

    CrossRef

  28. 28
    T.-C. Tseng, C.-J. Liu, T.-H. Su, H.-C. Yang, C.-C. Wang, C.-L. Chen, S. F.-T. Kuo, C.-H. Liu, P.-J. Chen, D.-S. Chen, J.-H. Kao, Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation, Journal of Infectious Diseases, 2012, 206, 10, 1521

    CrossRef

  29. 29
    Stephanos J. Hadziyannis, Natural history of chronic hepatitis B in Euro-Mediterranean and African Countries, Journal of Hepatology, 2011, 55, 1, 183

    CrossRef

  30. 30
    Syed-Mohammed R. Jafri, Anna Suk-Fong Lok, Antiviral Therapy for Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 425

    CrossRef

  31. 31
    Anna S. F. Lok, Francesco Negro, Hepatitis B and D,
  32. 32
    Yun-Fan Liaw, Natural History of Chronic Hepatitis B Virus Infection,
  33. 33
    Hellan K. Kwon, Anna S.F. Lok, Treatment of Hepatitis B,